Human Immunodeficiency Virus-1 Infection: Developing Systemic Drug Products for Pre-Exposure Prophylaxis
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 18, 2019
October 29, 2019
954b4104-b554-475b-90aa-d413f78e97c8
Related Documents
Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention Guidance for Industry
Guidance DocumentNovember 18, 2019Center for Drug Evaluation and Research
Anthrax: Developing Drugs for Prophylaxis of Inhalational Anthrax Guidance for Industry
Guidance DocumentMay 24, 2018Center for Drug Evaluation and Research
Vulvovaginal Candidiasis: Developing Drugs for Treatment
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox